DXCM241206C64000
- 0.00
- 0.000.00%
DexCom Newsroom
The annual "big reshuffling" of the Nasdaq 100 is about to begin! Who is expected to join, and who will be eliminated?
This year's potential high-flying stocks like palantir, MSTR and more are expected to be included.
Unusual Options Activity: PINS, MCHP and Others Attract Market Bets, PINS V/OI Ratio Reaches 333.3
EST Dec 3rd Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
United States Diabetes Device Market Forecast Report and Company Analysis 2024-2032 Featuring BD, Roche, Medtronic, Insulet, Abbott, Dexcom, Tandem Diabetes Care, Ypsomed Novo Nordisk, Eli Lilly - ResearchAndMarkets.com
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
3 Reasons to Buy DexCom Stock Like There's No Tomorrow
The Return Trends At DexCom (NASDAQ:DXCM) Look Promising
Is DexCom, Inc. (NASDAQ:DXCM) Potentially Undervalued?
Why Is DexCom, Inc. (DXCM) Among the Worst Performing Healthcare Stocks in 2024?
DexCom, Inc. (DXCM): Innovation and Growth Catalysts Amid Strong Long-Term Outlook for Diabetes Care
BofA Securities Maintains DexCom(DXCM.US) With Buy Rating
Express News | Dexcom Inc : Leerink Partners Cuts Target Price to $86 From $87
Dexcom's G7 Hospital CGM Poised for Market Breakthrough With NTAP and FDA Approvals
Here's Why DexCom (DXCM) Declined In Q3
Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $90
Wells Fargo Sticks to Its Buy Rating for Dexcom (DXCM)
These 10 Laggard Stocks Could Get Hit Further by Tax-Loss Selling
DexCom Pairs Its Glucose Monitor With Oura's Smart Ring -- Barrons.com
DexCom, ŌURA Enter Strategic Partnership; Dexcom Is Investing $75M In Ōura Series D Funding
Oura Valued at $5 Billion in Deal With Glucose Device Maker Dexcom
Dexcom and ŌURA Announce Strategic Partnership